18:34:19 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-18 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-04-23 Ordinarie utdelning GETI B 4.40 SEK
2024-04-22 Årsstämma 2024
2024-04-22 Kvartalsrapport 2024-Q1
2024-02-01 Bokslutskommuniké 2023
2023-10-23 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-04-27 Ordinarie utdelning GETI B 4.25 SEK
2023-04-26 Kvartalsrapport 2023-Q1
2023-04-26 Årsstämma 2023
2023-02-01 Bokslutskommuniké 2022
2022-10-19 Kvartalsrapport 2022-Q3
2022-07-19 Kvartalsrapport 2022-Q2
2022-04-27 Ordinarie utdelning GETI B 4.00 SEK
2022-04-26 Kvartalsrapport 2022-Q1
2022-04-26 Årsstämma 2022
2022-01-28 Bokslutskommuniké 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-04-21 Ordinarie utdelning GETI B 3.00 SEK
2021-04-20 Kvartalsrapport 2021-Q1
2021-04-20 Årsstämma 2021
2021-01-28 Bokslutskommuniké 2020
2020-10-16 Kvartalsrapport 2020-Q3
2020-07-16 Kvartalsrapport 2020-Q2
2020-06-29 Ordinarie utdelning GETI B 1.50 SEK
2020-06-26 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-01-30 Bokslutskommuniké 2019
2019-10-18 Kvartalsrapport 2019-Q3
2019-07-17 Kvartalsrapport 2019-Q2
2019-04-24 Ordinarie utdelning GETI B 1.00 SEK
2019-04-23 Kvartalsrapport 2019-Q1
2019-04-23 Årsstämma 2019
2019-01-30 Bokslutskommuniké 2018
2018-10-18 Kvartalsrapport 2018-Q3
2018-07-17 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning GETI B 1.50 SEK
2018-04-26 Årsstämma 2018
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-29 Bokslutskommuniké 2017
2017-10-18 Kvartalsrapport 2017-Q3
2017-07-17 Kvartalsrapport 2017-Q2
2017-04-25 Kvartalsrapport 2017-Q1
2017-03-30 Ordinarie utdelning GETI B 2.00 SEK
2017-03-29 Årsstämma 2017
2017-01-26 Bokslutskommuniké 2016
2016-10-18 Kvartalsrapport 2016-Q3
2016-07-14 Kvartalsrapport 2016-Q2
2016-04-22 Kvartalsrapport 2016-Q1
2016-03-31 Ordinarie utdelning GETI B 2.80 SEK
2016-03-30 Årsstämma 2016
2016-01-28 Bokslutskommuniké 2015
2015-10-15 Kvartalsrapport 2015-Q3
2015-09-02 Extra Bolagsstämma 2015
2015-07-15 Kvartalsrapport 2015-Q2
2015-04-20 Kvartalsrapport 2015-Q1
2015-03-26 Ordinarie utdelning GETI B 2.80 SEK
2015-03-25 Årsstämma 2015
2015-01-28 Bokslutskommuniké 2014
2014-10-16 Kvartalsrapport 2014-Q3
2014-10-16 Analytiker möte 2014
2014-07-15 Kvartalsrapport 2014-Q2
2014-04-16 Kvartalsrapport 2014-Q1
2014-03-21 Ordinarie utdelning GETI B 4.15 SEK
2014-03-20 Årsstämma 2014
2014-01-28 Bokslutskommuniké 2013
2013-10-15 Analytiker möte 2013
2013-10-15 15-7 2013
2013-10-15 Kvartalsrapport 2013-Q3
2013-07-11 Kvartalsrapport 2013-Q2
2013-04-17 Kvartalsrapport 2013-Q1
2013-03-22 Ordinarie utdelning GETI B 4.15 SEK
2013-03-21 Årsstämma 2013
2013-02-08 Kapitalmarknadsdag 2013
2013-01-25 Bokslutskommuniké 2012
2012-10-17 Kvartalsrapport 2012-Q3
2012-10-17 Analytiker möte 2012
2012-07-11 Kvartalsrapport 2012-Q2
2012-04-19 Kvartalsrapport 2012-Q1
2012-03-29 Ordinarie utdelning GETI B 3.75 SEK
2012-03-28 Årsstämma 2012
2012-01-26 Bokslutskommuniké 2011
2011-10-20 Kvartalsrapport 2011-Q3
2011-07-11 Kvartalsrapport 2011-Q2
2011-04-28 Ordinarie utdelning GETI B 3.25 SEK
2011-04-27 Årsstämma 2011
2011-04-27 Kvartalsrapport 2011-Q1
2011-01-28 Kapitalmarknadsdag 2011
2011-01-26 Bokslutskommuniké 2010
2010-10-19 Kvartalsrapport 2010-Q3
2010-04-23 Ordinarie utdelning GETI B 2.75 SEK
2010-04-22 Ordinarie utdelning GETI B 2.75 SEK
2010-04-21 Årsstämma 2010
2010-04-21 Kvartalsrapport 2010-Q1
2010-01-26 Bokslutskommuniké 2009
2009-07-13 Kvartalsrapport 2009-Q2
2009-05-06 Kvartalsrapport 2009-Q3
2009-04-22 Ordinarie utdelning GETI B 2.40 SEK
2009-04-21 Årsstämma 1
2009-04-21 Kvartalsrapport 2009-Q1
2008-04-18 Ordinarie utdelning GETI B 2.40 SEK
2007-04-20 Ordinarie utdelning GETI B 2.20 SEK
2006-04-21 Ordinarie utdelning GETI B 2.00 SEK
2005-04-20 Ordinarie utdelning GETI B 1.65 SEK
2004-04-22 Ordinarie utdelning GETI B 1.35 SEK
2003-11-25 Split GETI B 1:4
2003-04-24 Ordinarie utdelning GETI B 4.25 SEK
2002-04-19 Ordinarie utdelning GETI B 3.75 SEK
2001-04-24 Ordinarie utdelning GETI B 3.50 SEK
2000-04-28 Ordinarie utdelning GETI B 3.50 SEK
1999-04-22 Ordinarie utdelning GETI B 3.25 SEK
1998-04-24 Ordinarie utdelning GETI B 2.75 SEK
1997-04-30 Ordinarie utdelning GETI B 2.50 SEK
1996-04-19 Ordinarie utdelning GETI B 6.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är en global leverantör av tekniska lösningar för sjukvårdsindustrin. Bolaget är en utvecklare samt tillverkare av lösningar som används inom operationssalar, intensivvårdsenheter och sterilcentraler. Bolagets produkter används exempelvis för infektionskontroll, bland IT-system, patienthantering, samt vid vård av kraftigt överviktiga patienter. Huvudkontoret ligger i Göteborg.
2022-11-21 16:10:00

U.S. Food & Drug Administration (FDA) will include Getinge's subsidiary Datascope as an additional facility in the company's existing consent decree with the U.S Government. This is due to findings from previous FDA inspections and a warning letter related to operational compliance with the company's quality management system and processes.

Getinge has today responded to FDA and accepted that Datascope will be included in the existing Consent Decree. FDA's conclusion relates to a previously communicated warning letter in 2019 and subsequent inspections at the Datascope site in Wayne, NJ, US, between November 1, 2021 and January 21, 2022. According to FDA, Getinge's subsidiary Datascope has failed to fully comply with the Quality Management System and related processes.
Datascope is enforcing the ongoing actions to address the findings from the inspections and warning letter and to ensure that the organization act in compliance with the Quality Management System. The company is implementing a new operational quality organization with new leadership closer and integrated in the business operations. A work plan for further improvements for the site will be submitted to FDA in January 2023, in accordance with standard procedure and an independent auditor will be appointed.

Datascope's improvement activities 2018-2022 amount to approx. SEK 500 M from 2018. The additional costs for the improvements going forward are not expected to be material.

Datascope is a subsidiary of Getinge, and manufacturer of life-supporting medical devices such as Intra-Aortic Balloon Pumps. Datascope's products are sold globally and will continue to be available for customers.

Phone Conference

A conference call will be held on November 21, 2022, at 5.00 p.m. (17:00) CET hosted by Mattias Perjos, President & CEO. Please see dial in details below to join the conference:

Sweden: +46 856642651
United Kingdom: +44 3333000804
United States: +1 6319131422
PIN: 12992271#
During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/press-conference-november-2022

Alternatively, use the following link to download the presentation: https://www.getinge.com/int/company/investors/reports-presentations/

Media contact:

Lars Mattsson, Head of Investor Relations
Phone: +46 (0)10 335 0043
Email: lars.mattsson@getinge.com

Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
Email: anna.appelqvist@getinge.com

This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on November 21, 2022, at 16.10 CET.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.